Related Experiment Video
Updated: Apr 7, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
HLH and spinal neurofibroma: a single case report in a patient with DiGeorge syndrome
Ramona Tallone1, Concetta Micalizzi2, Maura Faraci3
1Diagnosis, Observation, and Prevention after Oncological therapy (D.O.P.O.) Clinic, Department of Pediatric Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy.
Background:
DiGeorge syndrome is a rare genetic disorder with variable phenotypic and immunologic features associated to an increased risk of malignancy. Hemophagocytic lymphohistiocytosis (HLH) is a rare hyperinflammatory condition that can be triggered by infectious complications in immunodeficient patients like those with DGS.
Case:
We report the case of a 20-year-old female with intellectual and motor disabilities who was diagnosed with non-familial HLH at age of 12 months and underwent allogeneic hematopoietic stem cell transplantation due to early disease reactivation. Despite resolution of HLH and post-transplant GVHD, the patient's psychomotor delay persisted, and dysmorphic features became more pronounced. A an array-CGH on her fibroblasts was performed and identified a partial de novo deletion on chromosome 22, consistent with DiGeorge Syndrome (DGS). At 15 years, imaging performed because of persistent and worsening back pain, revealed an intraneural/intraradicular atypical neurofibroma which was partially resected leading to symptoms disappearance.
Conclusion:
This is the first report of a case of DGS with early onset HLH and late occurrence of a neoplasm of uncertain biological potential. Careful clinical monitoring is essential due to the variability in clinical manifestations and level of immune alteration.
More Related Videos
04:33Spinal Hernia Repair and Cauda Equina Repositioning After Lumbar Decompression under Three-Dimensional Microscopy: A Case Report and Literature Review
Published on: November 8, 2024
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024